Workflow
subunit protein nano - based technology
icon
Search documents
Novavax, Inc. (NVAX) Presents at Jefferies London Healthcare Conference 2025 Transcript
Seeking Alpha· 2025-11-19 19:33
Core Insights - Novavax has shifted its strategic focus and aims to leverage its unique technology to differentiate itself in the market [1] Company Overview - Novavax is recognized for developing a highly effective COVID vaccine during the pandemic, a feat not achieved by many larger pharmaceutical companies [1] - The company's success is attributed to its core technology, which utilizes subunit protein nano-based technology for antigen creation, combined with the effective adjuvant Matrix-M [1][2]